We constructed a radiotherapy-resistance GC cell line and performed a series of in vitro assays such as Immunoblot, CCK-8, and FCM, and the results revealed that SHMT2 was highly expressed in radiotherapy-resistance GC cells and reduced the radiosensitivity of GC cells, and stimulate cell apoptosis. This evidence concerns the gene SHMT2 and gastric cancer.